Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Trial
The PEACE-PAIN trial study design is supported by patient survey responses but may benefit from modifications, namely incorporating thorough discussions of the current evidence for efficacy, safety, tolerability, and approaches to address adverse effects of psilocybin. Additionally, the interest in participation by individuals with prior psychedelic use holds important methodological implications for the inclusion/exclusion criteria of the trial.
Authors
- Kaylyssa Philip (ORCID: https://orcid.org/0000-0002-9207-9427)
- Cheryl Pritlove (ORCID: https://orcid.org/0000-0001-9627-7562)
- Joel D Katz (ORCID: https://orcid.org/0000-0002-8686-447X)
- Duminda N. Wijeysundera (ORCID: https://orcid.org/0000-0002-5897-8605)
- Jiwon Lee (ORCID: https://orcid.org/0000-0002-7903-1883)
- Hance A. Clarke (ORCID: https://orcid.org/0000-0003-4975-3823)
- Karim Shiraz Ladha (ORCID: https://orcid.org/0000-0001-7303-2458)
- Paul Ritvo (ORCID: https://orcid.org/0000-0003-1141-0083)
- Muhammad Ishrat Husain (ORCID: https://orcid.org/0000-0001-5771-5750)
- Akash Goel (ORCID: https://orcid.org/0000-0001-8545-9782)
Institutions
- St. Michael's Hospital (CA)
- University Health Network (CA)
- Centre for Addiction and Mental Health (CA)
- University of Toronto (CA)
- York University (CA)
- Public Health Ontario (CA)
Publication Details
- Journal
- Canadian Journal of Pain
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1080/24740527.2024.2406285
- Citations
- 2
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.28